MP9 - Evaluating Methodologies for Monitoring Designer Drug Exposure and Comparing Results
Monday, May 5, 2025
11:45 AM – 12:15 PM ET
Location: Hall BCD
Clinicians have multiple options for monitoring treatment adherence. Multiple guidelines recommend using combinations of methods, each having benefits and considerations. This study compared results utilizing point-of-care (POC) analysis cups compared to liquid chromatography/tandem mass spectrometry (LC/MS/MS) analysis of the same urine sample. The analysis explores differences in detection of various designer drugs and potential false positive results identified by POC analysis. The purpose of the analysis is not to discourage utilization of POC tools. Additional information may be gained from appropriate use of enhanced analytical methods, which may allow for more informed treatment decisions and improved outcomes.
Learning Objectives:
Describe differences in analysis methodologies and their potential impact on results.
List examples of designer drugs that detection of recent use could be impacted by the analysis methodology selected.
Discuss applications for detection of recent designer drug exposure on client education and informing treatment decisions.
